Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma.
Ren J, Amoozgar Z, Uccello TP, Lei PJ, Zhao Y, Ho WW, Huang P, Kardian A, Mack SC, Duda DG, Xu L, Jain RK.
Ren J, et al. Among authors: lei pj.
Proc Natl Acad Sci U S A. 2025 Jan 28;122(4):e2319474122. doi: 10.1073/pnas.2319474122. Epub 2025 Jan 22.
Proc Natl Acad Sci U S A. 2025.
PMID: 39841145